Infectious Disease

Merck and Orna Therapeutics team up to advance next generation RNA tech

16-Aug-2022 By Rachel Arthur

Merck and Orna Therapeutics have announced a collaboration agreement to discover, develop and commercialize Orna’s next generation oRNA technology across multiple programs, including vaccines and therapeutics in infectious disease and oncology.

Vaccibody becomes Nykode Therapeutics, teams up with Regeneron on cancer vaccines

23-Nov-2021 By Jane Byrne

Vaccibody, a Norway-based pioneer in the neoantigen cancer vaccine space, has changed its name to Nykode Therapeutics, and has entered into a license and collaboration agreement with US company, Regeneron, to develop vaccines against cancer and infectious...

UK biotech body creates new strategic goals for investment in research

10-Aug-2021 By Nick Taylor

A UK body that provides £75m (€88m) a year for research into biotechnology and biological sciences has changed its approach to investment.

CEPI funds trials against emerging infectious disease

03-Jun-2020 By Ben Hargreaves

With many organizations pivoting to work on the pandemic, CEPI partners with consortium to develop a vaccine against the Chikungunya virus.

Strategic partnership forms single-source solution for biopharma

10-Jan-2017 By Melissa Fassbender

CSSi LifeSciences and BioMARC have announced a strategic partnership to provide 'fully cohesive product development and support' for vaccine and biologic development. 

PPD Expands Central Lab Services in Brussels, Singapore

14-Feb-2013 By Zachary Brennan

PPD has expanded its central lab testing services at its Brussels and Singapore labs and will offer additional services in microbiology, peripheral blood mononuclear cell and molecular pathology services.